-
Minocycline HCl in Scalable EV & Neuroinflammation Research
2026-06-19
Minocycline HCl is redefining experimental standards in both scalable extracellular vesicle (EV) workflows and neuroinflammation research. This article delivers protocol-focused guidance, troubleshooting, and evidence-based innovations that empower labs to harness the full translational potential of minocycline hydrochloride from APExBIO.
-
O-propargyl-puromycin (OPP) for High-Fidelity Protein Synthe
2026-06-19
O-propargyl-puromycin (OPP) empowers researchers to precisely quantify nascent protein synthesis in living cells, unlocking nuanced insights into translational control and mitochondrial regulation. This guide details actionable workflows, troubleshooting, and advanced applications in immunology and proteomics research.
-
Fasudil (HA-1077) HCl: ROCK Inhibition and Hippo Pathway Cro
2026-06-18
Explore how Fasudil (HA-1077) HCl, a potent ROCK inhibitor, enables advanced research into Rho/ROCK and Hippo pathway interactions—offering unique insights for cancer and cell biology studies. Discover protocol nuances and translational implications that set this guide apart.
-
miR-18a/ALOXE3 Axis Drives Ferroptosis Resistance in Gliobla
2026-06-18
Yang et al. uncover that miR-18a promotes glioblastoma progression by suppressing ALOXE3, resulting in impaired ferroptosis and enhanced tumor cell migration via altered lipid signaling. This mechanistic insight highlights the miR-18a/ALOXE3 axis as a promising molecular target for future therapeutic strategies in glioblastoma.
-
TG003 Cdc2-like Kinase Inhibitor: Precision in Splicing Rese
2026-06-17
TG003 enables researchers to dissect alternative splicing with nanomolar precision, advancing both cancer and neuromuscular disease models. Its robust selectivity for Clk kinases fuels innovative workflows in splice modulation and therapy development.
-
Iptacopan (LNP023): Translational Impact in Complement Disea
2026-06-17
Explore the translational significance of Iptacopan (LNP023) in complement-mediated disease models. This in-depth analysis reveals advanced applications, unique assay considerations, and protocol parameters not found in other reviews.
-
BI 2536: PLK1 Inhibitor Workflows for Cell Cycle and Cancer
2026-06-16
BI 2536 stands out as a gold-standard PLK1 inhibitor, enabling precise dissection of mitotic checkpoint control, G2/M arrest, and apoptosis in cancer models. This guide delivers protocol enhancements, troubleshooting, and actionable insights grounded in landmark research and verified vendor data.
-
Chlorpromazine HCl: Dopamine Receptor Antagonist in Cell Ent
2026-06-16
Chlorpromazine HCl stands out not only for its canonical dopamine receptor antagonism but also as a rigorously validated tool for dissecting endocytic pathways in cell biology. This article translates recent reference advances into actionable workflows, troubleshooting insights, and protocol refinements for neuropharmacology and infection mechanism studies.
-
Catalpol in Disease Models: Applied Workflows and Troublesho
2026-06-15
Catalpol, a multi-target iridoid glycoside from APExBIO, empowers translational research across neuroprotection, osteoporosis, and ischemic stroke models with reproducible performance. This article synthesizes validated experimental protocols, practical troubleshooting, and actionable insights from peer-reviewed studies for robust assay design.
-
HSBP7 Loss Restores Contractility in Titin Cardiomyopathy Mo
2026-06-15
This study introduces CARDIO, a high-content morphological profiling platform, and uses it to identify HSPB7 as a genetic modifier capable of rescuing contractile dysfunction in titin-mutant cardiomyocytes. The findings provide a new systems-level approach to uncovering therapeutic targets in heart failure, with implications for precision cardiology.
-
Imipramine’s Mechanistic Leverage: From Antidepressant to Tr
2026-06-14
Imipramine, once defined by its clinical use as a tricyclic antidepressant, is now at the forefront of translational research targeting autophagy, apoptosis, and tumor biology. This article elucidates the mechanistic rationale, experimental best practices, and translational potential of Imipramine, weaving in the latest lipidomics and virology insights to guide next-generation research.
-
RWJ 67657: Precision p38 MAPK Inhibition in Inflammatory Mod
2026-06-13
RWJ 67657 (JNJ-3026582) empowers researchers with selective, dual-action inhibition of p38α/β MAP kinases, enabling reliable cytokine modulation in complex inflammatory disease workflows. This practical guide delivers integrated protocol parameters, troubleshooting strategies, and actionable insights drawn from recent structural and translational research breakthroughs.
-
TaqI Restriction Endonuclease: Fast, Reliable DNA Digestion
2026-06-12
TaqI Restriction Endonuclease (SKU K3053) addresses the need for rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA in molecular biology workflows. It is ideal where fast turnaround is required, but should not be used for diagnostic or clinical applications.
-
SLC25A1 Drives Cisplatin Resistance via H3K27ac-Linked Senes
2026-06-12
Li et al. (2026) reveal that SLC25A1 upregulation in head and neck squamous cell carcinoma (HNSCC) promotes cisplatin resistance through H3K27 acetylation-mediated cellular senescence. This mechanistic insight establishes SLC25A1 as a predictive biomarker and therapeutic target, with implications for senescence assay design in oncology research.
-
p-Cresyl sulfate (A8895): Reliable Tool for Endothelial Dysf
2026-06-11
This article guides biomedical researchers through real-world challenges in cardiovascular and renal disease modeling, focusing on the use of p-Cresyl sulfate (SKU A8895) for robust, reproducible assays. Scenario-driven Q&A blocks address compatibility, mechanistic depth, and data interpretation, with workflow recommendations grounded in primary literature and the APExBIO product dossier.
450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page